{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-05-19",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "10",
          "submission_status": "AP",
          "submission_status_date": "20210611",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "67783",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/212614s008s010lbl.pdf",
              "date": "20210614",
              "type": "Label"
            },
            {
              "id": "67806",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/204629Orig1s028, s029; 206073Orig1s027, s030; 206111Orig1s025, s026; 208658Orig1s013, s015; 212614Orig1s008, s010ltr.pdf",
              "date": "20210615",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "29",
          "submission_status": "AP",
          "submission_status_date": "20251024",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "83934",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2025/212614s029lbl.pdf",
              "date": "20251027",
              "type": "Label"
            },
            {
              "id": "83935",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2025/212614s029lbl.pdf#page=44",
              "date": "20251027",
              "type": "Medication Guide"
            },
            {
              "id": "83955",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/204629Orig1s063,206111Orig1s046,208658Orig1s034,206073Orig1s044,212614Orig1s029ltr.pdf",
              "date": "20251028",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20200127",
          "review_priority": "STANDARD",
          "submission_class_code": "TYPE 4",
          "submission_class_code_description": "Type 4 - New Combination",
          "application_docs": [
            {
              "id": "61702",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212614s000lbl.pdf",
              "date": "20200128",
              "type": "Label"
            },
            {
              "id": "61705",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/212614Orig1s000ltr.pdf",
              "date": "20200128",
              "type": "Letter"
            },
            {
              "id": "64830",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/nda/2020/212614Orig1s000TOC.html",
              "date": "20201005",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "8",
          "submission_status": "AP",
          "submission_status_date": "20210611",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "67784",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2021/212614s008s010lbl.pdf",
              "date": "20210614",
              "type": "Label"
            },
            {
              "id": "67805",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/204629Orig1s028, 206073Orig1s027, 206111Orig1s025, 208658Orig1s013, 212614Orig1s008ltr.pdf",
              "date": "20210628",
              "type": "Letter"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "16",
          "submission_status": "AP",
          "submission_status_date": "20221013",
          "review_priority": "901 REQUIRED",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "72326",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/212614Orig1s016ltr.pdf",
              "date": "20221014",
              "type": "Letter"
            },
            {
              "id": "72485",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/212614s016lbl.pdf",
              "date": "20221028",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "4",
          "submission_status": "AP",
          "submission_status_date": "20201030",
          "review_priority": "STANDARD",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "65133",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/212614Orig1s004ltr.pdf",
              "date": "20201103",
              "type": "Letter"
            },
            {
              "id": "65142",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/212614s004lbl.pdf",
              "date": "20201103",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "20",
          "submission_status": "AP",
          "submission_status_date": "20231030",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "76003",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/212614s020lbl.pdf",
              "date": "20231031",
              "type": "Label"
            },
            {
              "id": "76014",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/206073Orig1s036; 206111Orig1s042; 208658Orig1s028; 212614Orig1s020ltr.pdf",
              "date": "20231031",
              "type": "Letter"
            }
          ]
        }
      ],
      "application_number": "NDA212614",
      "sponsor_name": "BOEHRINGER INGELHEIM",
      "openfda": {
        "application_number": [
          "NDA212614"
        ],
        "brand_name": [
          "TRIJARDY XR"
        ],
        "generic_name": [
          "EMPAGLIFLOZIN, LINAGLIPTIN, METFORMIN HYDROCHLORIDE"
        ],
        "manufacturer_name": [
          "Boehringer Ingelheim Pharmaceuticals, Inc."
        ],
        "product_ndc": [
          "0597-0380",
          "0597-0395",
          "0597-0385",
          "0597-0390"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "ORAL"
        ],
        "substance_name": [
          "EMPAGLIFLOZIN",
          "LINAGLIPTIN",
          "METFORMIN HYDROCHLORIDE"
        ],
        "rxcui": [
          "2359279",
          "2359285",
          "2359288",
          "2359290",
          "2359351",
          "2359353",
          "2359356",
          "2359358"
        ],
        "spl_id": [
          "ca86ce8b-9c04-47d8-94e3-ae041f251fab"
        ],
        "spl_set_id": [
          "71873567-9594-452a-bb92-34a129adecac"
        ],
        "package_ndc": [
          "0597-0395-23",
          "0597-0395-82",
          "0597-0395-52",
          "0597-0380-68",
          "0597-0380-13",
          "0597-0380-22",
          "0597-0385-86",
          "0597-0385-77",
          "0597-0385-88",
          "0597-0390-13",
          "0597-0390-71",
          "0597-0390-31"
        ],
        "nui": [
          "N0000175912",
          "N0000175913",
          "N0000187059",
          "N0000187058"
        ],
        "pharm_class_moa": [
          "Dipeptidyl Peptidase 4 Inhibitors [MoA]",
          "Sodium-Glucose Transporter 2 Inhibitors [MoA]"
        ],
        "pharm_class_epc": [
          "Dipeptidyl Peptidase 4 Inhibitor [EPC]",
          "Sodium-Glucose Cotransporter 2 Inhibitor [EPC]"
        ],
        "unii": [
          "3X29ZEJ4R2",
          "HDC1R2M35U",
          "786Z46389E"
        ]
      },
      "products": [
        {
          "product_number": "004",
          "reference_drug": "Yes",
          "brand_name": "TRIJARDY XR",
          "active_ingredients": [
            {
              "name": "EMPAGLIFLOZIN",
              "strength": "25MG"
            },
            {
              "name": "LINAGLIPTIN",
              "strength": "5MG"
            },
            {
              "name": "METFORMIN HYDROCHLORIDE",
              "strength": "1GM"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "TABLET, EXTENDED RELEASE",
          "route": "ORAL",
          "marketing_status": "Prescription"
        },
        {
          "product_number": "002",
          "reference_drug": "Yes",
          "brand_name": "TRIJARDY XR",
          "active_ingredients": [
            {
              "name": "EMPAGLIFLOZIN",
              "strength": "10MG"
            },
            {
              "name": "LINAGLIPTIN",
              "strength": "5MG"
            },
            {
              "name": "METFORMIN HYDROCHLORIDE",
              "strength": "1GM"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "TABLET, EXTENDED RELEASE",
          "route": "ORAL",
          "marketing_status": "Prescription"
        },
        {
          "product_number": "003",
          "reference_drug": "Yes",
          "brand_name": "TRIJARDY XR",
          "active_ingredients": [
            {
              "name": "EMPAGLIFLOZIN",
              "strength": "12.5MG"
            },
            {
              "name": "LINAGLIPTIN",
              "strength": "2.5MG"
            },
            {
              "name": "METFORMIN HYDROCHLORIDE",
              "strength": "1GM"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "TABLET, EXTENDED RELEASE",
          "route": "ORAL",
          "marketing_status": "Prescription"
        },
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "TRIJARDY XR",
          "active_ingredients": [
            {
              "name": "EMPAGLIFLOZIN",
              "strength": "5MG"
            },
            {
              "name": "LINAGLIPTIN",
              "strength": "2.5MG"
            },
            {
              "name": "METFORMIN HYDROCHLORIDE",
              "strength": "1GM"
            }
          ],
          "reference_standard": "No",
          "dosage_form": "TABLET, EXTENDED RELEASE",
          "route": "ORAL",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}